KIR2DL3 and cancer: We further showed that multimerizing IL-15 to NKG2A targeting increased degranulation and IFN-γ expression of NK cells against resistant cancer cells expressing multiple HLAs [69], while KIR2DL targeting did not show a significant effect probably due to reduced receptor expression.